Finance

Aclaris Therapeutics, a clinical-stage biopharmaceutical company specializing in the development of novel drug candidates for immuno-inflammatory diseases, witnessed a decline in its stock today following

Clearmind Medicine Inc, a pioneering biotech company specializing in the exploration and advancement of innovative psychedelic-derived therapeutics for addressing significant under-treated health concerns, declared the

Nauticus Robotics, a pioneer in autonomous subsea robotics, has successfully concluded a financial overhaul aimed at eliminating dilutive warrants and ratchet provisions from its original